Acetylation Reader Proteins: Linking Acetylation Signaling to Genome Maintenance and Cancer

Area of Science:

• Epigenetics and Molecular Biology
• Cancer Research
• Genomic Stability

Background:

• Chromatin modifications, including histone acetylation, are vital for DNA damage response (DDR) pathways.
• Dysregulation of DDR and acetylation pathways is common in cancer, leading to genomic instability.
• Histone acetyltransferases (HATs) and histone deacetylases (HDACs) control lysine acetylation, a key post-translational modification.

Purpose of the Study:

• To discuss the role of histone acetylation pathways, focusing on acetylation reader proteins, in promoting genome stability and DDR.
• To analyze the impact of acetylation signaling on DDR within the context of cancer and its treatments.
• To highlight the importance of understanding epigenetic regulators, DDR, and chromatin for developing novel cancer therapies.

Main Methods:

• Review and analysis of existing literature on histone acetylation, DNA damage response, and cancer.
• Focus on the function of bromodomain (BRD) proteins as acetyl-lysine readers in DDR.
• Examination of how acetylation dynamics regulate chromatin structure and protein interactions during DNA damage.

Main Results:

• Histone acetylation dynamics are critical for regulating chromatin accessibility and protein interactions essential for DDR.
• Bromodomain proteins act as key readers of acetylated histones, mediating crucial DDR activities.
• Aberrant acetylation signaling in cancer impacts DDR, presenting therapeutic targets.

Conclusions:

• Histone acetylation pathways, especially mediated by BRD proteins, are fundamental for maintaining genome stability and effective DDR.
• Targeting epigenetic regulators like HATs, HDACs, and BRD proteins, alongside DDR pathways, shows promise for cancer treatment.
• A comprehensive understanding of the interplay between epigenetic regulators, DDR, and chromatin is essential for advancing cancer therapy.